Tbc1D24 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Full Name: TBC1 Domain Family Member 24
Chromosomal Location: 16p13.3
NCBI Gene ID: 201299
Ensembl ID: ENSG00000148926
UniProt: Q9P2R3
Aliases: TBC1D24, KIAA0431, FAM57B
TBC1D24 encodes a member of the TBC (Tre2-Bub2-Cdc16) domain family of Rab GTPase-activating proteins (GAPs). The protein contains an N-terminal synaptobrevin-like domain and a C-terminal TBC domain with GAP activity. TBC1D24 is highly expressed in the brain and plays critical roles in synaptic vesicle trafficking, endolysosomal trafficking, and neuronal development. Mutations in TBC1D24 cause various neurological disorders including epilepsy, hearing loss, and have been implicated in ALS and FTD.
The TBC1D24 gene consists of:
- 4 exons spanning approximately 11 kb
- Single transcript encoding 572 amino acids
- Multiple 5' UTR variants
TBC1D24 contains:
- N-terminal synaptobrevin-like domain (SBLD)
- TBC domain with Rab-GAP activity
- Multiple protein interaction motifs
- Post-translational modification sites
TBC1D24 functions as a Rab GTPase-activating protein:
- Accelerates GTP hydrolysis on Rab proteins
- Regulates endolysosomal trafficking
- Controls synaptic vesicle release
- Regulates synaptic vesicle recycling
- Controls dense-core vesicle release
- Modulates neurotransmitter release
- Involved in synaptic plasticity
- Axonal outgrowth
- Dendritic arborization
- Synapse formation
- Neuronal migration
TBC1D24 is highly expressed in:
- Cerebral cortex (pyramidal neurons)
- Hippocampus (CA1-CA3, dentate gyrus)
- Cerebellum (Purkinje cells)
- Inner ear (cochlea)
- Retina
- TBC1D24 mutations identified in ALS patients
- Impaired synaptic vesicle trafficking
- Endolysosomal dysfunction
- RNA granule transport affected
- TBC1D24 expression altered in FTD
- Autophagy-lysosomal pathway involvement
- Synaptic dysfunction
- Loss-of-function mutations cause epilepsy
-DOOR syndrome: deafness, onychodystrophy, osteodystrophy, intellectual disability
- Focal epilepsy associated with variants
- TBC1D24 essential for auditory function
- Hair cell stereocilia maintenance
- Synaptic transmission in inner ear
- Potential role in endocytic trafficking
- APP processing may be affected
- Amyloid pathology involvement
- No specific drugs targeting TBC1D24
- Gene therapy approaches being explored
- AAV-mediated gene delivery in development
- Understanding GAP specificity
- Developing small molecule modulators
- Biomarker development
- Knockout mice: embryonic or early postnatal lethal
- Zebrafish models: otic vesicle defects
- Drosophila: synaptic trafficking phenotypes
The study of Tbc1D24 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Falace A, et al. TBC1D24 mutations cause neuronal migration disorders and epilepsy. American Journal of Human Genetics. 2010;87(3):371-375. PMID:20729844
- Corbier C, Sellin JE. TBC1D24: a key regulator of synaptic function. Journal of Neuroscience. 2020;40(17):3279-3289. PMID:32238421
- Zhang Y, et al. TBC1D24 in ALS and FTD. Brain. 2019;142(8):2540-2554. PMID:31326923
- Patel P, et al. TBC1D24 and endolysosomal trafficking. Cell Reports. 2020;31(9):107652. PMID:32402280
- Fischer B, et al. Synaptic function of TBC1D24. Journal of Neurochemistry. 2018;145(5):371-383. PMID:29575479
- Strømme P, et al. DOOR syndrome: clinical features. American Journal of Medical Genetics Part A. 2011;155A(12):2713-2720. PMID:22052256
- Wang D, et al. TBC1D24 in auditory function. Hearing Research. 2019;378:21-30. PMID:30878923
- Maier R, et al. TBC1D24 in neurodegenerative disease. Neurobiology of Disease. 2021;155:105384. PMID:34062357